G d’Ancona

1.4k total citations
71 papers, 910 citations indexed

About

G d’Ancona is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, G d’Ancona has authored 71 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Physiology, 30 papers in Pulmonary and Respiratory Medicine and 16 papers in Surgery. Recurrent topics in G d’Ancona's work include Asthma and respiratory diseases (42 papers), Eosinophilic Esophagitis (15 papers) and Respiratory and Cough-Related Research (8 papers). G d’Ancona is often cited by papers focused on Asthma and respiratory diseases (42 papers), Eosinophilic Esophagitis (15 papers) and Respiratory and Cough-Related Research (8 papers). G d’Ancona collaborates with scholars based in United Kingdom, Ireland and Canada. G d’Ancona's co-authors include Brian D. Kent, David J. Jackson, Cris Roxas, Jaideep Dhariwal, Linda K. Green, Louise Thomson, Alexandra M. Nanzer, Joanne Kavanagh, Mariana Fernandes and A Hearn and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Thorax.

In The Last Decade

G d’Ancona

69 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G d’Ancona United Kingdom 16 643 578 159 155 128 71 910
Douglas C. Cowan United Kingdom 15 864 1.3× 559 1.0× 116 0.7× 143 0.9× 252 2.0× 29 1.0k
J. Almeida Portugal 11 234 0.4× 234 0.4× 51 0.3× 19 0.1× 17 0.1× 21 434
Meghan Wilson United States 14 544 0.8× 362 0.6× 17 0.1× 195 1.3× 6 0.0× 44 823
John‐Helge Heimdal Norway 20 1.1k 1.7× 1.1k 1.9× 14 0.1× 71 0.5× 61 0.5× 49 1.4k
Anna Suling Germany 17 218 0.3× 144 0.2× 8 0.1× 152 1.0× 19 0.1× 35 884
Mark Millard United States 10 299 0.5× 488 0.8× 17 0.1× 24 0.2× 28 0.2× 29 659
Hatice Keleş Türkiye 13 168 0.3× 114 0.2× 10 0.1× 86 0.6× 26 0.2× 24 478
Emmanuelle Rochette France 12 63 0.1× 42 0.1× 27 0.2× 45 0.3× 37 0.3× 55 431
Takeshi Nishiyama Japan 13 54 0.1× 79 0.1× 13 0.1× 140 0.9× 19 0.1× 20 474
Muhanned Abu‐Hijleh United States 12 84 0.1× 354 0.6× 8 0.1× 120 0.8× 4 0.0× 21 589

Countries citing papers authored by G d’Ancona

Since Specialization
Citations

This map shows the geographic impact of G d’Ancona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G d’Ancona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G d’Ancona more than expected).

Fields of papers citing papers by G d’Ancona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G d’Ancona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G d’Ancona. The network helps show where G d’Ancona may publish in the future.

Co-authorship network of co-authors of G d’Ancona

This figure shows the co-authorship network connecting the top 25 collaborators of G d’Ancona. A scholar is included among the top collaborators of G d’Ancona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G d’Ancona. G d’Ancona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Green, Linda K., Mariana Fernandes, Louise Thomson, et al.. (2025). Clinical and Biological Remission With Tezepelumab: The Real‐World Response in Severe Uncontrolled Asthma. Allergy. 80(6). 1669–1676. 9 indexed citations
2.
d’Ancona, G, Linda K. Green, Mariana Fernandes, et al.. (2025). Adherence to Inhaled Corticosteroids and Clinical Outcomes Following a Year of Tezepelumab Therapy for Severe Asthma. The Journal of Allergy and Clinical Immunology In Practice. 14(3). 637–643.e2.
3.
Nanzer, Alexandra M., G d’Ancona, Claire Hopkins, et al.. (2025). Tezepelumab in Patients With Eosinophilic Granulomatosis With Polyangiitis After Suboptimal Response to Anti-IL-5/5R Therapy. CHEST Journal. 168(5). 1093–1096. 1 indexed citations
4.
Nanzer, Alexandra M., Linda K. Green, Louise Thomson, et al.. (2024). Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis. The Journal of Allergy and Clinical Immunology In Practice. 12(3). 724–732. 13 indexed citations
5.
Jackson, David J., Matthew A. Coleman, G d’Ancona, et al.. (2024). An international consensus on the use of asthma biologics in pregnancy. The Lancet Respiratory Medicine. 13(1). 80–91. 9 indexed citations
6.
Clements, J. Clancy, et al.. (2023). The role of the clinical pharmacist in the respiratory or sleep multidisciplinary team. Breathe. 19(4). 230123–230123. 1 indexed citations
7.
8.
d’Ancona, G, Joanne Kavanagh, Jaideep Dhariwal, et al.. (2021). Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma. Allergy. 76(7). 2238–2241. 18 indexed citations
9.
Hearn, A, Joanne Kavanagh, G d’Ancona, et al.. (2021). Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy. European Respiratory Journal. 57(6). 2100166–2100166. 3 indexed citations
10.
Nanzer, Alexandra M., et al.. (2021). Transitioning Asthma Care From Adolescents to Adults. CHEST Journal. 160(4). 1192–1199. 12 indexed citations
11.
Pérez‐Carbonell, Laura, Valentina Gnoni, Seán Higgins, et al.. (2020). Adherence to wakefulness promoting medication in patients with narcolepsy. Sleep Medicine. 70. 50–54. 15 indexed citations
12.
Nanzer, Alexandra M., Jaideep Dhariwal, Joanne Kavanagh, et al.. (2020). Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis. ERJ Open Research. 6(4). 451–2020. 31 indexed citations
13.
d’Ancona, G, Joanne Kavanagh, Cris Roxas, et al.. (2020). Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma. European Respiratory Journal. 55(5). 1902259–1902259. 57 indexed citations
14.
Nanzer, Alexandra M., Cris Roxas, Mariana Fernandes, et al.. (2020). Prevalence and recovery of adrenal insufficiency in steroid-dependent asthma patients receiving biologic therapy. European Respiratory Journal. 56(1). 1902273–1902273. 12 indexed citations
15.
Kent, Brian D., G d’Ancona, Mariana Fernandes, et al.. (2020). Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis. ERJ Open Research. 6(1). 311–2019. 26 indexed citations
16.
Kavanagh, Joanne, A Hearn, G d’Ancona, et al.. (2020). Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma. Allergy. 76(6). 1890–1893. 35 indexed citations
17.
Kavanagh, Joanne, A Hearn, Jaideep Dhariwal, et al.. (2020). Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma. CHEST Journal. 159(2). 496–506. 187 indexed citations
18.
Bloom, Chloë I., et al.. (2019). Cost saving of switching to equivalent inhalers and its effect on health outcomes. Thorax. 74(11). 1078–1086. 22 indexed citations
19.
Drakatos, Panagis, Dimosthenis Lykouras, G d’Ancona, et al.. (2017). Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice. Sleep Medicine. 35. 80–84. 33 indexed citations
20.
Lane, Jennifer C. E., et al.. (2013). Improving prescribing in paediatric cleft surgery: Developing an online order set. International Journal of Surgery. 11(8). 678–678. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas C. Cowan Breakdown of academic impact, for papers by J. Almeida Breakdown of academic impact, for papers by Meghan Wilson Breakdown of academic impact, for papers by John‐Helge Heimdal Breakdown of academic impact, for papers by Anna Suling Breakdown of academic impact, for papers by Mark Millard Breakdown of academic impact, for papers by Hatice Keleş Breakdown of academic impact, for papers by Emmanuelle Rochette Breakdown of academic impact, for papers by Takeshi Nishiyama Breakdown of academic impact, for papers by Muhanned Abu‐Hijleh
Rankless by CCL
2026